Search Results - "Uzunel, Mehmet"

Refine Results
  1. 1

    Fetal Membrane Cells for Treatment of Steroid‐Refractory Acute Graft‐Versus‐Host Disease by Ringdén, Olle, Erkers, Tom, Nava, Silvia, Uzunel, Mehmet, Iwarsson, Erik, Conrad, Réka, Westgren, Magnus, Mattsson, Jonas, Kaipe, Helen

    Published in Stem cells (Dayton, Ohio) (01-03-2013)
    “…The placenta protects the fetus from the mother's immune system. We have previously found that fetal membrane cells (FMCs) isolated from term placenta prevent…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant? by Stikvoort, Arwen, Sundin, Mikael, Uzunel, Mehmet, Gertow, Jens, Sundberg, Berit, Schaffer, Marie, Mattsson, Jonas, Uhlin, Michael

    Published in PloS one (06-05-2016)
    “…Long-term stable mixed chimerism is a rare and poorly understood phenomenon post hematopoietic stem cell transplantation. This study aims to shed light on…”
    Get full text
    Journal Article
  4. 4

    T Cell Receptor Excision Circle (TREC) Monitoring after Allogeneic Stem Cell Transplantation; a Predictive Marker for Complications and Clinical Outcome by Gaballa, Ahmed, Sundin, Mikael, Stikvoort, Arwen, Abumaree, Muhamed, Uzunel, Mehmet, Sairafi, Darius, Uhlin, Michael

    “…Allogeneic hematopoietic stem cell transplantation (HSCT) is a well-established treatment modality for a variety of malignant diseases as well as for inborn…”
    Get full text
    Journal Article
  5. 5

    Thymic function after allogeneic stem cell transplantation is dependent on graft source and predictive of long term survival by Sairafi, Darius, Mattsson, Jonas, Uhlin, Michael, Uzunel, Mehmet

    Published in Clinical immunology (Orlando, Fla.) (01-03-2012)
    “…Abstract T-cell deficiency after allogeneic stem cell transplantation (ASCT) is common and has major impact on clinical outcome. In this retrospective study…”
    Get full text
    Journal Article
  6. 6

    A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation by Uhlin, Michael, Okas, Mantas, Gertow, Jens, Uzunel, Mehmet, Brismar, Torkel B., Mattsson, Jonas

    Published in CANCER IMMUNOLOGY IMMUNOTHERAPY (01-03-2010)
    “…Epstein–Barr virus (EBV)-related malignancies such as post-transplant lymphoproliferative disease (PTLD) are severe complications after allogeneic stem cell…”
    Get full text
    Journal Article
  7. 7

    Eleven percent intact PGM3 in a severely immunodeficient patient with a novel splice-site mutation, a case report by Lundin, Karin E, Wang, Qing, Hamasy, Abdulrahman, Marits, Per, Uzunel, Mehmet, Wirta, Valtteri, Wikström, Ann-Charlotte, Fasth, Anders, Ekwall, Olov, Smith, C I Edvard

    Published in BMC pediatrics (29-08-2018)
    “…A novel immunodeficiency, frequently accompanied by high serum-IgE, and caused by mutations in the PGM3 gene was described in 2014. To date there are no unique…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Maternal microchimerism in human fetal tissues by Jonsson, Anna Maria, MD, Uzunel, Mehmet, PhD, Götherström, Cecilia, PhD, Papadogiannakis, Nikos, MD, PhD, Westgren, Magnus, MD, PhD

    “…Objective The aim of the present study was to analyze the presence of maternal cells in human fetal tissues in the second trimester. Study Design Tissues from…”
    Get full text
    Journal Article
  10. 10

    A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation by Le Blanc, Katarina, Remberger, Mats, Uzunel, Mehmet, Mattsson, Jonas, Barkholt, Lisbeth, Ringdén, Olle

    Published in Transplantation (15-10-2004)
    “…Nonmyeloablative (NM) conditioning and reduced-intensity conditioning (RIC) are increasingly used for allogeneic hematopoietic stem-cell transplantation. Such…”
    Get full text
    Journal Article
  11. 11

    Inhibition of Heavy Chain and β2-Microglobulin Synthesis as a Mechanism of Major Histocompatibility Complex Class I Downregulation during Epstein-Barr Virus Replication by ORTLIEB GUERREIRO -CACAIS, Andre, UZUNEL, Mehmet, LEVITSKAYA, Jelena, LEVITSKY, Victor

    Published in Journal of Virology (01-02-2007)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  12. 12

    The TNFd4 allele is correlated to moderate‐to‐severe acute graft‐versus‐host disease after allogeneic stem cell transplantation by Nordlander, Anna, Uzunel, Mehmet, Mattsson, Jonas, Remberger, Mats

    Published in British journal of haematology (01-12-2002)
    “…Certain cytokine gene polymorphisms may be associated with severe acute graft‐versus‐host disease (GVHD) after allogeneic stem cell transplantation. The…”
    Get full text
    Journal Article
  13. 13

    Adult porcine islets produce MCP-1 and recruit human monocytes in vitro by Ehrnfelt, Cecilia, Kumagai-Braesch, Makiko, Uzunel, Mehmet, Holgersson, Jan

    Published in Xenotransplantation (Københaven) (01-03-2004)
    “…:  Type 1 diabetes can be cured by transplantation of isolated pancreatic islets. Because of the shortage of human donor tissue, adult porcine islets (APIs)…”
    Get full text
    Journal Article
  14. 14

    Single‐exon approach to non‐invasive fetal RHD screening in early pregnancy: An update after 10years' experience by Uzunel, Mehmet, Tiblad, Eleonor, Mörtberg, Anette, Wikman, Agneta

    Published in Vox sanguinis (01-11-2022)
    “…Background and ObjectivesAnti‐D prophylaxis, administered to RhD‐negative women, has significantly reduced the incidence of RhD immunization. Non‐invasive…”
    Get full text
    Journal Article
  15. 15

    Single‐exon approach to non‐invasive fetal RHD screening in early pregnancy: An update after 10 years' experience by Uzunel, Mehmet, Tiblad, Eleonor, Mörtberg, Anette, Wikman, Agneta

    Published in Vox sanguinis (01-11-2022)
    “…Background and Objectives Anti‐D prophylaxis, administered to RhD‐negative women, has significantly reduced the incidence of RhD immunization. Non‐invasive…”
    Get full text
    Journal Article
  16. 16

    Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells by Le Blanc, Katarina, Rasmusson, Ida, Sundberg, Berit, Götherström, Cecilia, Hassan, Moustapha, Uzunel, Mehmet, Ringdén, Olle

    Published in The Lancet (British edition) (01-05-2004)
    “…Adult bone-marrow-derived mesenchymal stem cells are immunosuppressive and prolong the rejection of mismatched skin grafts in animals. We transplanted…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease by Ringdén, Olle, Uzunel, Mehmet, Rasmusson, Ida, Remberger, Mats, Sundberg, Berit, Lönnies, Helena, Marschall, Hanns-Ulrich, Dlugosz, Aldona, Szakos, Attila, Hassan, Zuzana, Omazic, Brigitta, Aschan, Johan, Barkholt, Lisbeth, Le Blanc, Katarina

    Published in Transplantation (27-05-2006)
    “…Mesenchymal stem cells (MSC) have immunomodulatory effects. The aim was to study the effect of MSC infusion on graft-versus-host disease (GVHD). We gave MSC to…”
    Get full text
    Journal Article
  19. 19

    Rapid Salvage Treatment With Virus-Specific T Cells for Therapy-Resistant Disease by Uhlin, Michael, Gertow, Jens, Uzunel, Mehmet, Okas, Mantas, Berglund, Sofia, Watz, Emma, Brune, Mats, Ljungman, Per, Maeurer, Mark, Mattsson, Jonas

    Published in Clinical infectious diseases (15-10-2012)
    “…Background. Viral infections are major complications after allogeneic hematopoietic stem cell transplantation (HSCT). During posttransplant immunosuppression…”
    Get full text
    Journal Article
  20. 20